Phase i & II - CPP

Ended Definitive Contract Awarded Last action

Contract number
W81XWH13C0167
Awardee
Awarding agency
Obligated
$13,622,857

Award facts

Contract value 64% obligated
  • $13,622,857.04 Current, with exercised options
  • $21,348,638.04 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Hinckley, OH 44233, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00026 -$115,815
Other Administrative Action P00025 $0
Funding Only Action P00024 -$94,989
Change Order P00023 $433,930
Funding Only Action P00022 · Incremental funding in the amount of $164,103.25 to clin 0001. $164,103
Change Order P00021 $257,409
Other Administrative Action P00020 $0
Other Administrative Action P00019 $464,069
Other Administrative Action P00018 · Administrative modification to correct erroneous error. $0
Funding Only Action P00017 · Increase the ceiling to clin 0001 phase i & II - CPP, and extend POP to 31 DEC 2019. $0
Funding Only Action P00016 · Provide incremental funding for cryopreserved platelets (CPP)manufacturing to improve battlefield management of severe hemorrhage due to wounding. $999,556
Funding Only Action P00015 · Phase i & II - CPP incremental funding $1,101,757
Funding Only Action P00014 -$2,685
Funding Only Action P00013 $770,000
Change Order P00012 $795,116
Other Administrative Action P00011 · Development of manufacturing, warehousing, and delivery of a cryopreserved platelets (CPP) product to support efforts to obtain U.S. Food and drug… $0
Funding Only Action P00010 $37,178
Other Administrative Action P00009 $0
Other Administrative Action P00008 $244,888
Other Administrative Action P00007 $0
Change Order P00006 $60,500
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Change Order P00003 $68,362
Other Administrative Action P00002 $0
Funding Only Action P00001 $4,941,948
Original award $3,497,530
Show all 27

About this award

Written by GovTribe AI ·

This is a cost-plus-fixed-fee definitive federal contract awarded by the U.S. Army Medical Command (MEDCOM) to Icon Government and Public Health Solutions, Inc., a foreign-owned, for-profit organization. The $21,348,638.04 contract supports Phase I & II of an unspecified clinical research program, with a completion date of June 30, 2020. The contract does not utilize any set-aside designations, indicating open competition. Major subcontractors include the University of Cincinnati, Origen Biomedical, Inc., Leidos Holdings, Inc., Vitalant Research Institute, and Trustees of Dartmouth College. The contract supports a wide range of clinical research services, including protocol development, study execution, data management, and participant recruitment, with a focus on medical countermeasure development for infectious diseases, chemical/biological threats, and public health emergencies. Icon Government and Public Health Solutions holds several significant Indefinite Delivery Vehicle (IDV) contracts with federal agencies like the National Institute of Allergy and Infectious Diseases, expanding its clinical trial capabilities across the government.

Quick answers

Who was awarded contract W81XWH13C0167?

W81XWH13C0167 was awarded to Icon Government And Public Health Solutions, Inc. by Medical Command (Department of the Army) on September 11, 2013.

How much is contract W81XWH13C0167 worth?

The government has obligated $13,622,857 on W81XWH13C0167. Its potential value, with all options, is $21,348,638.

Was contract W81XWH13C0167 competed?

The extent of competition for W81XWH13C0167 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login